TONICK
ActiveSummary
TONICK has been active since 2017 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €39,673 and a net result of €14,839. Equity is growing by ~6.3% per year across the filed fiscal years. Its solvency ranks better than 39% of 19923 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability95▼-5
Solvency81▼-19
Growth32▼-46
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €3,000 at 30 days acceptable
Liquidity ample (current ratio 1.98 against 4.41 in 2023; short-term debt: 41.2% and cash: 19.9% of total assets), and 43.9% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Four signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
56.1%
Return on assets
21%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 31-07-2025, 0 days ahead of the deadline.
NBB · 8 filingsDeviation from the deadline
2025
not confirmed
2024
on the day
2023
30 d late
2022
60 d late
2021
82 d late
2020
108 d late
2019
84 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 61 days after the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark What changed in the latest annual accounts?What changed
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€39,673▼ 46.5%
2023 · €74,160
Total assets
€70,681▼ 27.4%
2023 · €97,422
Net result
€14,839▼ 51.1%
2023 · €30,370
Working capital
€28,626▼ 52.0%
2023 · €59,582
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€31,518▲ 182%€22,023▼ 30.1%€26,123▲ 18.6%€44,730▲ 71.2%€23,938▼ 46.5%
Net result€22,187within the sector's middle half▲ 378%€14,288below the sector's middle half▼ 35.6%€16,951below the sector's middle half▲ 18.6%€30,370within the sector's middle half▲ 79.2%€14,839below the sector's middle half▼ 51.1%
Equity€73,392within the sector's middle half▲ 43.4%€71,792within the sector's middle half▼ 2.2%€84,909within the sector's middle half▲ 18.3%€74,160within the sector's middle half▼ 12.7%€39,673below the sector's middle half▼ 46.5%
Total assets€125,013below the sector's middle half▲ 33.5%€113,652below the sector's middle half▼ 9.1%€108,389below the sector's middle half▼ 4.6%€97,422below the sector's middle half▼ 10.1%€70,681below the sector's middle half▼ 27.4%
Debt€49,121▲ 22.9%€39,360▼ 19.9%€23,480▼ 40.3%€23,262▼ 0.9%€31,008▲ 33.3%
Working capital€62,823within the sector's middle half▲ 50.2%€56,753within the sector's middle half▼ 9.7%€59,545within the sector's middle half▲ 4.9%€59,582within the sector's middle half▲ 0.1%€28,626within the sector's middle half▼ 52.0%
Solvency58.7%within the sector's middle half▲ 4.1pp63.2%within the sector's middle half▲ 4.5pp78.3%within the sector's middle half▲ 15.2pp76.1%within the sector's middle half▼ 2.2pp56.1%within the sector's middle half▼ 20.0pp
Current ratio3.16within the sector's middle half▲ 0.823.06within the sector's middle half▼ 0.103.84within the sector's middle half▲ 0.784.41within the sector's middle half▲ 0.571.98within the sector's middle half▼ 2.43
Return on assets (ROA)17.7%within the sector's middle half▲ 12.8pp12.6%within the sector's middle half▼ 5.2pp15.6%within the sector's middle half▲ 3.1pp31.2%within the sector's middle half▲ 15.5pp21.0%within the sector's middle half▼ 10.2pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result falls in 2024; 2024 is 46% below 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €70,681
Fixed assets
€12,907 ▼ 36.7%
Current assets
€57,774 ▼ 25.0%
Equity and liabilities €70,681
Equity
€39,673 ▼ 46.5%
Debt
€31,008 ▲ 33.3%
Debt's share of the balance-sheet total rises from 23.9% to 43.9%. Equity is lower and debt is higher.
Key figures and ratios
EBITDA
€33,257▼
2023 · €53,247
Cash flow
€24,157▼
2023 · €38,887
Debt to equity
0.78▲
2023 · 0.31
ROE
37.4%▼
2023 · 41.0%
Interest coverage
32.48▼
2023 · 65.23
Debt ≤ 1 year
€29,148▲
2023 · €17,448
Debt > 1 year
€1,260▼
2023 · €5,791
Income taxes
€8,469▼
2023 · €13,582
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 26,970 companies that looked in July 2024 the way this one looks now, 1.5% went bankrupt within 24 months and 95% are still going.
- Micro
- 5 to 10 years old
- solvency 30% or more
- a profit of 5% of the balance sheet or more
1.5%
went bankrupt
3.4%
stopped otherwise
95%
still going
A further 0.3% stopped, but we cannot tell whether within those 24 months.
For this company itself Checked computes a lower bankruptcy probability: 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 26,970 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €12,384 | €10,235 | €8,105 | €8,517 | €9,319 | ▲ 9.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €725 | - | - |
| Provisions for liabilities and charges: additions (uses and reversals)635/8 | - | - | -€2,500 | - | - | - |
| Other operating charges640/8 | - | €4,539 | €1,089 | €5,495 | €3,138 | ▼ 42.9% |
| Gross operating margin9900 | €50,156 | €36,797 | €32,817 | €59,467 | €36,395 | ▼ 38.8% |
| Operating profit (loss)9901 | €31,518 | €22,023 | €26,123 | €44,730 | €23,938 | ▼ 46.5% |
| Financial income75/76B | - | €544 | €620 | €38 | €393 | ▲ 936% |
| Recurring financial income75 | €688 | €544 | €620 | €38 | €393 | ▲ 936% |
| Financial charges65/66B | - | €1,346 | €1,107 | €816 | €1,024 | ▲ 25.4% |
| Recurring financial charges65 | €1,361 | €1,346 | €1,107 | €816 | €1,024 | ▲ 25.4% |
| Profit (loss) for the period before taxes9903 | €30,845 | €21,221 | €25,637 | €43,952 | €23,308 | ▼ 47.0% |
| Income taxes67/77 | €8,658 | €6,933 | €8,686 | €13,582 | €8,469 | ▼ 37.6% |
| Profit (loss) for the period9904 | €22,187 | €14,288 | €16,951 | €30,370 | €14,839 | ▼ 51.1% |
| Profit (loss) for the period to be appropriated9905 | €22,187 | €14,288 | €16,951 | €30,370 | €14,839 | ▼ 51.1% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €125,013 | €113,652 | €108,389 | €97,422 | €70,681 | ▼ 27.4% |
| Fixed assets21/28 | €33,149 | €29,397 | €27,892 | €20,393 | €12,907 | ▼ 36.7% |
| Tangible fixed assets22/27 | €33,149 | €29,397 | €27,892 | €20,393 | €12,907 | ▼ 36.7% |
| Plant, machinery and equipment23 | - | €1,187 | - | - | - | - |
| Furniture and vehicles24 | - | €26,892 | €25,932 | €12,404 | €5,160 | ▼ 58.4% |
| Leasing and similar rights25 | - | - | - | €5,208 | €4,049 | ▼ 22.3% |
| Other tangible fixed assets26 | - | €1,318 | €1,959 | €2,781 | €3,699 | ▲ 33.0% |
| Current assets29/58 | €91,863 | €84,254 | €80,497 | €77,030 | €57,774 | ▼ 25.0% |
| Amounts receivable after more than one year29 | - | €30,000 | €30,494 | - | - | - |
| Other amounts receivable291 | - | €30,000 | €30,494 | - | - | - |
| Amounts receivable within one year40/41 | €35,003 | €25,797 | €30,765 | €38,238 | €37,892 | ▼ 0.9% |
| Trade receivables40 | - | €25,797 | €30,765 | €38,238 | €37,892 | ▼ 0.9% |
| Cash at bank and in hand54/58 | €19,663 | €21,364 | €12,654 | €31,051 | €14,076 | ▼ 54.7% |
| Deferred charges and accrued income490/1 | - | €7,094 | €6,586 | €7,740 | €5,807 | ▼ 25.0% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €125,013 | €113,652 | €108,389 | €97,422 | €70,681 | ▼ 27.4% |
| Equity10/15 | €73,392 | €71,792 | €84,909 | €74,160 | €39,673 | ▼ 46.5% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €7,953 | €7,953 | €7,953 | €7,953 | €7,953 | = |
| Non-distributable reserves130/1 | - | €1,860 | €1,860 | - | - | - |
| Reserves not available under the articles1311 | - | €1,860 | €1,860 | - | - | - |
| Tax-exempt reserves132 | - | €6,093 | €6,093 | €6,093 | €6,093 | = |
| Distributable reserves133 | - | - | - | €1,860 | €1,860 | = |
| Profit (loss) carried forward14 | €46,839 | €45,239 | €58,356 | €47,608 | €13,121 | ▼ 72.4% |
| Provisions and deferred taxes16 | €2,500 | €2,500 | - | - | - | - |
| Provisions for liabilities and charges160/5 | - | €2,500 | - | - | - | - |
| Other liabilities and charges164/5 | - | €2,500 | - | - | - | - |
| Amounts payable17/49 | €49,121 | €39,360 | €23,480 | €23,262 | €31,008 | ▲ 33.3% |
| Amounts payable after more than one year17 | €20,081 | €11,858 | €2,527 | €5,791 | €1,260 | ▼ 78.2% |
| Financial debts170/4 | - | €11,858 | €2,527 | €5,791 | €1,260 | ▼ 78.2% |
| Amounts payable within one year42/48 | €29,040 | €27,501 | €20,953 | €17,448 | €29,148 | ▲ 67.1% |
| Current portion of amounts payable after more than one year42 | - | €12,454 | €13,952 | €6,943 | €6,229 | ▼ 10.3% |
| Trade debts44 | €1,301 | €1,016 | €1,807 | €3,346 | €2,436 | ▼ 27.2% |
| Suppliers440/4 | - | €1,016 | €1,807 | €3,346 | €2,436 | ▼ 27.2% |
| Taxes, remuneration and social security45 | - | €5,831 | €4,619 | €6,372 | €8,666 | ▲ 36.0% |
| Taxes450/3 | - | €5,831 | €4,619 | €6,372 | €8,666 | ▲ 36.0% |
| Other amounts payable47/48 | - | €8,201 | €575 | €787 | €11,816 | ▲ 1,402% |
| Accrued charges and deferred income492/3 | - | - | - | €23 | €600 | ▲ 2,553% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €22,187 | €14,288 | €16,951 | €30,370 | €14,839 | ▼ 51.1% |
| + Depreciation and write-downs630 | €12,384 | €10,235 | €8,105 | €8,517 | €9,319 | ▲ 9.4% |
| Operating cash flow (approximation) | €34,572 | €24,523 | €25,056 | €38,887 | €24,157 | ▼ 37.9% |
| Investment in fixed assets (approximation) | - | -€6,483 | -€6,599 | -€1,018 | -€1,833 | ▼ 80.1% |
| Change in cash | - | €1,700 | -€8,710 | €18,398 | -€16,976 | ▼ 192% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
31-12
Financial
Highest result since 2018net €30,370 ▲79.2%
Operating result €44,730, net result €30,370, both a record.
29-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 60 days late
2022
21-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 82 days late
2021
16-11
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 108 days late
2020
23-10
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 84 days late
2019
31-12
Financial
Weakest financial yearnet €4,646 ▼74%
Net result drops to €4,646, the lowest in the series; recovery starts the following year.
27-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 27 days late
2018
28-09
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 59 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 3 acts read
About the unread acts
We know of 3 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
3 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Liège · 1 establishment unit since 2017
Ground area
435 m²
Building footprint
32 m²
Volume, LiDAR
207 m³
Parcel 62302C0157/02R000, Wallonia · tallest building 7.7 m, ±2 floors. Linked by address, not a title deed.
2
companies at this address
See who is registered here
1 establishment unit
Rue Joseph-Willem 24, 4030 Liège
since 20172.270.754.162
1 parcel
Wallonia
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 62302C0157/02R000 | Wallonia | 435 m² | 1 · 32 m² | 7.7 m · 2 fl. |
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
Dr. F. Bakal
BE 0738.907.396
Antwerpen · Eq €39,702
Dr. Tania Claeys
BE 1012.911.117
Brugge · Eq €39,703
Dr. MRSM
BE 1012.723.748
Zoersel · Eq €39,732
Dr. Lieselot Deblaere
BE 0758.578.602
Ieper · Eq €39,610
DRLR Cabinet médical
BE 0684.508.214
Stoumont · Eq €39,760
Of 16,631 companies in sector 86220 we hold annual accounts for 7,985. 4,616 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded19-09-2017
Fiscal year end31-12
Activities, NACEBEL 2025
86220Specialist medical practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0681516951
Also
9925:BE0681516951
Registered
05-02-2026
Register as of 27 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.